Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05178524
What this trial is testing

Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

Who this might be right for
Gut MicrobiotaHepatocellular CarcinomaBifidobacterium
Tongji Hospital 180
Not applicableLooking for participantsNCT06434480
What this trial is testing

SBRT in HCC With Oligoprogression on First-line Immunotherapy

Who this might be right for
HCC
Chinese University of Hong Kong 30
Large-scale testing (Phase 3)Ended earlyNCT02460991
What this trial is testing

ONCO-DOX in Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cell Carcinoma
Boston Scientific Corporation 2
Not applicableUnknownNCT03652896
What this trial is testing

Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma by BCLC Stage
Huazhong University of Science and Technology 60
Post-approval studies (Phase 4)Active Not RecruitingNCT03024684
What this trial is testing

Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

Who this might be right for
HepatoCellular Carcinoma
Chiayi Christian Hospital 240
Testing effectiveness (Phase 2)WithdrawnNCT02406508
What this trial is testing

Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Delcath Systems Inc.
Testing effectiveness (Phase 2)WithdrawnNCT01669668
What this trial is testing

Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma)

Who this might be right for
Carcinoma, Hepatocellular
Washington University School of Medicine
Post-approval studies (Phase 4)Study completedNCT01203787
What this trial is testing

Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Florida 120
Testing effectiveness (Phase 2)Study completedNCT01934829
What this trial is testing

Urea Cream Treatment Sorafenib-Associated HSFR in HCC

Who this might be right for
Hepatocellular Carcinoma
Chinese Anti-Cancer Association 871
Not applicableUnknownNCT03609268
What this trial is testing

Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma

Who this might be right for
Recurrent Hepatocellular CarcinomaMicrowave AblationStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 110
Testing effectiveness (Phase 2)UnknownNCT05173610
What this trial is testing

Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma

Who this might be right for
Oligometastasis Hepatocellular Carcinoma
Yonsei University 40
Not applicableStudy completedNCT02272504
What this trial is testing

A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers

Who this might be right for
CirrhosisChronic Liver Diseases
Wako Life Sciences 2,500
Not applicableLooking for participantsNCT04907643
What this trial is testing

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Who this might be right for
Cancer PainVisceral PainGastrointestinal Neoplasms+76 more
Cedars-Sinai Medical Center 360
Not applicableLooking for participantsNCT04745390
What this trial is testing

Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Metastases
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 110
Testing effectiveness (Phase 2)Study completedNCT01850368
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Korea Cancer Center Hospital 35
Not applicableStudy completedNCT06899763
What this trial is testing

Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)MASLD-HCCHCV_HCC
Fondazione IRCCS Policlinico San Matteo di Pavia 6
Not applicableEnded earlyNCT02585687
What this trial is testing

Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hospices Civils de Lyon 28
Not applicableLooking for participantsNCT04221893
What this trial is testing

Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers

Who this might be right for
Stage IV Esophageal AdenocarcinomaStage IV Esophageal Squamous Cell CarcinomaStage IV Gastric Cancer+41 more
University of California, San Francisco 28
Large-scale testing (Phase 3)UnknownNCT04167293
What this trial is testing

Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT06679985
What this trial is testing

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Coherus Oncology, Inc. 72
Next Page